ÂÜÀòÂÒÂ×

Dan has over 15 years of consulting experience focused on commercialization strategy for pipeline assets as well as life-cycle management. He has expertise in designing and executing custom quantitative and qualitative primary market research and building accurate asset and portfolio forecasts across the seven major markets and beyond. He is well-versed in a wide variety of therapeutic areas including rare diseases, immunology, CNS disorders, oncology, renal disease, pulmonary disease, and cardiovascular disease.